EPO_HORSE
ID EPO_HORSE Reviewed; 192 AA.
AC Q867B1;
DT 10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT 01-JUN-2003, sequence version 1.
DT 03-AUG-2022, entry version 83.
DE RecName: Full=Erythropoietin;
DE Flags: Precursor;
GN Name=EPO;
OS Equus caballus (Horse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
OX NCBI_TaxID=9796;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Kidney;
RX PubMed=14719696; DOI=10.2460/ajvr.2004.65.15;
RA Sato F., Yamashita S., Kugo T., Hasegawa T., Mitsui I., Kijima-Suda I.;
RT "Nucleotide sequence of equine erythropoietin and characterization of
RT region-specific antibodies.";
RL Am. J. Vet. Res. 65:15-19(2004).
CC -!- FUNCTION: Hormone involved in the regulation of erythrocyte
CC proliferation and differentiation and the maintenance of a
CC physiological level of circulating erythrocyte mass. Binds to EPOR
CC leading to EPOR dimerization and JAK2 activation thereby activating
CC specific downstream effectors, including STAT1 and STAT3.
CC {ECO:0000250|UniProtKB:P01588}.
CC -!- SUBCELLULAR LOCATION: Secreted.
CC -!- SIMILARITY: Belongs to the EPO/TPO family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AB100030; BAC55239.1; -; mRNA.
DR RefSeq; NP_001075294.1; NM_001081825.1.
DR AlphaFoldDB; Q867B1; -.
DR SMR; Q867B1; -.
DR STRING; 9796.ENSECAP00000037030; -.
DR PaxDb; Q867B1; -.
DR Ensembl; ENSECAT00000011172; ENSECAP00000008707; ENSECAG00000010733.
DR GeneID; 100033849; -.
DR KEGG; ecb:100033849; -.
DR CTD; 2056; -.
DR VGNC; VGNC:51127; EPO.
DR GeneTree; ENSGT00390000017226; -.
DR InParanoid; Q867B1; -.
DR OrthoDB; 1175751at2759; -.
DR Proteomes; UP000002281; Chromosome 13.
DR Bgee; ENSECAG00000010733; Expressed in bone marrow and 8 other tissues.
DR ExpressionAtlas; Q867B1; baseline.
DR GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR GO; GO:0005125; F:cytokine activity; IBA:GO_Central.
DR GO; GO:0005128; F:erythropoietin receptor binding; ISS:UniProtKB.
DR GO; GO:0005179; F:hormone activity; IEA:UniProtKB-KW.
DR GO; GO:0030295; F:protein kinase activator activity; IBA:GO_Central.
DR GO; GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB.
DR GO; GO:0043249; P:erythrocyte maturation; IEA:UniProtKB-KW.
DR GO; GO:0038162; P:erythropoietin-mediated signaling pathway; ISS:UniProtKB.
DR GO; GO:0008284; P:positive regulation of cell population proliferation; IBA:GO_Central.
DR GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IBA:GO_Central.
DR Gene3D; 1.20.1250.10; -; 1.
DR InterPro; IPR009079; 4_helix_cytokine-like_core.
DR InterPro; IPR019767; EPO/TPO_CS.
DR InterPro; IPR001323; EPO_TPO.
DR InterPro; IPR003013; Erythroptn.
DR PANTHER; PTHR10370; PTHR10370; 1.
DR Pfam; PF00758; EPO_TPO; 1.
DR PIRSF; PIRSF001951; EPO; 1.
DR PRINTS; PR00272; ERYTHROPTN.
DR SUPFAM; SSF47266; SSF47266; 1.
DR PROSITE; PS00817; EPO_TPO; 1.
PE 2: Evidence at transcript level;
KW Disulfide bond; Erythrocyte maturation; Glycoprotein; Hormone;
KW Reference proteome; Secreted; Signal.
FT SIGNAL 1..26
FT /evidence="ECO:0000250"
FT CHAIN 27..192
FT /note="Erythropoietin"
FT /id="PRO_0000008400"
FT CARBOHYD 50
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 64
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 109
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT DISULFID 33..187
FT /evidence="ECO:0000250"
FT DISULFID 55..59
FT /evidence="ECO:0000250"
SQ SEQUENCE 192 AA; 20984 MW; E02D098490B09C4F CRC64;
MGVRECPALL LLLSLLLPPL GLPALGAPPR LICDSRVLER YILEAREAEN VTMGCAEGCS
FGENVTVPDT KVNFYSWKRM EVEQQAVEVW QGLALLSEAI LQGQALLANS SQPSETLRLH
VDKAVSSLRS LTSLLRALGA QKEAISPPDA ASAAPLRTFA VDTLCKLFRI YSNFLRGKLK
LYTGEACRRG DR